Successful treatment of type I adult-onset pityriasis rubra pilaris with infliximab

Australasian Journal of Dermatology

Volumn 47, Issue 2, 2006, Pages 124-129

  Manoharan, Shobhan ^a,c   White, Stephen ^a   Gumparthy, Krishna ^b  

^a CLATTERBRIDGE HOSPITAL   (United Kingdom)

^b ARROWE PARK HOSPITAL   (United Kingdom)

^c PRINCESS ALEXANDRA HOSPITAL   (Australia)

Author keywords

Acitretin; Dermatitis exfoliativa; Fumaric acid; Methotrexate; Monoclonal antibody; Mycophenolate mofetil; Papulosquamous; Tacrolimus; Tumour necrosis factor

Indexed keywords

ALLANTOIN; BETAMETHASONE DIPROPIONATE; CLOBETASOL PROPIONATE; COAL TAR; HYDROCORTISONE; INFLIXIMAB; KERATOLYTIC AGENT; METHOTREXATE; MICONAZOLE NITRATE; PREDNISOLONE; SALICYLIC ACID; TAR;

ADULT; ARTICLE; CASE REPORT; DIAGNOSTIC PROCEDURE; DISEASE ACTIVITY; ECTROPION; ERYTHEMA; ERYTHRODERMA; FEMALE; HUMAN; KERATOSIS PALMOPLANTARIS; NAIL; NAUSEA; PITYRIASIS RUBRA PILARIS; PRURITUS; SKIN BIOPSY; TREATMENT OUTCOME;

ABDOMEN; ANTIBODIES, MONOCLONAL; DERMATOLOGIC AGENTS; DIAGNOSIS, DIFFERENTIAL; DRUG ADMINISTRATION SCHEDULE; FEMALE; HAND; HUMANS; MIDDLE AGED; PITYRIASIS RUBRA PILARIS; THORAX; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33645519419     PISSN: 00048380     EISSN: 14400960     Source Type: Journal    
DOI: 10.1111/j.1440-0960.2006.00247.x     Document Type: Article

References (14)

1. Albert M Mackool B. Pityriasis rubra pilaris. Int. J. Dermatol. 1999 38 1 11.
2. Winterfield L Menter A. Psoriasis and its treatment with infliximab-mediated tumor necrosis factor α blockade. Dermatol. Clin. 2004 22 437 47.
3. Judge MR McLean WH Munro CS. Disorders of keratinization. In Burns T Breathnach S Cox N Griffiths C (eds). Rook's Textbook of Dermatology Vol. 2 7th edn. Oxford Blackwell Science 2004 34.1 111.
4. Goldsmith L Baden H. Pityriasis rubra pilaris. In Freedberg IM Eisen AZ Wolff K Austen KF Goldsmith LA Katz SI (eds). Fitzpatrick's Dermatology in General Medicine Vol. 1 6th edn. New York McGraw-Hill 2003 442 4.
5. Wetzig T Sticherling M. Juvenile pityriasis rubra pilaris: successful treatment with ciclosporin. Br. J. Dermatol. 2003 149 202 3.
6. Kirby B Watson R. Pityriasis rubra pilaris treated with acitretin and narrow-band ultraviolet B (Re-TL-01). Br. J. Dermatol. 2000 142 376 7.
7. Herbst R Vogelbruch M Ehnis A Kiehl P Kapp A Weiss J. Combined ultraviolet A1 radiation and acitretin therapy as a treatment option for pityriasis rubra pilaris. Br. J. Dermatol. 2000 142 574 5.
8. Kaskel P Peter R Kerscher M. Phototesting and phototherapy in pityriasis rubra pilaris. Br. J. Dermatol. 2001 144 430.
9. Haenssle H Bertsch P Emmert S Wolf C Zutt M. Extracorporeal photochemotherapy for the treatment of exanthematic pityriasis rubra pilaris. Clin. Exp. Dermatol. 2004 29 244 6.
10. Hofer A Mullegger R Kerl H Wolf P. Extracorporeal photochemotherapy for the treatment of erythrodermic pityriasis rubra pilaris. Arch. Dermatol. 1999 135 475 6.
11. Coras B Vogt T Ulrich H Landthaler M Hohenleutner U. Fumaric acid esters therapy: a new treatment modality in pityriasis rubra pilaris? Br. J. Dermatol. 2005 152 388 9.
12. Conaghan P Sommer S McGonagle D Veale D Waldmann H Hale G Goodfield M Emery P Isaacs J. The relationship between pityriasis rubra pilaris and inflammatory arthritis. Arthritis Rheum 1999 42 1998 2001.
13. Drosou A Kirsner R Welsh E Sullivan T Kerdel F. Use of infliximab, an anti-tumor necrosis alpha antibody, for inflammatory dermatoses. J. Cutan. Med. Surg. 2003 7 382 6.
14. Liao W Mutasim D. Infliximab for the treatment of adult-onset pityriasis rubra pilaris. Arch. Dermatol. 2005 141 423 5.